Assessing Transporter-Mediated Natural Product-Drug Interactions Via In vitro-In Vivo Extrapolation: Clinical Evaluation With a Probe Cocktail.
Adult
Alkaloids
/ pharmacokinetics
Biological Products
/ chemistry
Cross-Over Studies
Drug Evaluation
/ methods
Female
Furosemide
/ pharmacokinetics
HEK293 Cells
Herb-Drug Interactions
Humans
Hydrastis
/ chemistry
Male
Metformin
/ pharmacokinetics
Midazolam
/ pharmacokinetics
Organic Anion Transporters
/ antagonists & inhibitors
Organic Cation Transport Proteins
/ antagonists & inhibitors
Plant Extracts
/ chemistry
Rosuvastatin Calcium
/ pharmacokinetics
Journal
Clinical pharmacology and therapeutics
ISSN: 1532-6535
Titre abrégé: Clin Pharmacol Ther
Pays: United States
ID NLM: 0372741
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
received:
01
09
2020
accepted:
27
10
2020
pubmed:
12
11
2020
medline:
16
9
2021
entrez:
11
11
2020
Statut:
ppublish
Résumé
The botanical natural product goldenseal can precipitate clinical drug interactions by inhibiting cytochrome P450 (CYP) 3A and CYP2D6. Besides P-glycoprotein, effects of goldenseal on other clinically relevant transporters remain unknown. Established transporter-expressing cell systems were used to determine the inhibitory effects of a goldenseal extract, standardized to the major alkaloid berberine, on transporter activity. Using recommended basic models, the extract was predicted to inhibit the efflux transporter BCRP and uptake transporters OATP1B1/3. Using a cocktail approach, effects of the goldenseal product on BCRP, OATP1B1/3, OATs, OCTs, MATEs, and CYP3A were next evaluated in 16 healthy volunteers. As expected, goldenseal increased the area under the plasma concentration-time curve (AUC
Identifiants
pubmed: 33174626
doi: 10.1002/cpt.2107
pmc: PMC8058163
mid: NIHMS1647412
doi:
Substances chimiques
Alkaloids
0
Biological Products
0
Organic Anion Transporters
0
Organic Cation Transport Proteins
0
Plant Extracts
0
Furosemide
7LXU5N7ZO5
Rosuvastatin Calcium
83MVU38M7Q
Metformin
9100L32L2N
Midazolam
R60L0SM5BC
Types de publication
Clinical Trial
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1342-1352Subventions
Organisme : NCCIH NIH HHS
ID : U54 AT008909
Pays : United States
Informations de copyright
© 2020 The Authors. Clinical Pharmacology & Therapeutics © 2020 American Society for Clinical Pharmacology and Therapeutics.
Références
Mol Pharm. 2019 Jun 3;16(6):2342-2353
pubmed: 31039308
CPT Pharmacometrics Syst Pharmacol. 2018 Nov;7(11):739-747
pubmed: 30175555
Clin Pharmacol Ther. 2005 May;77(5):415-26
pubmed: 15900287
Mol Pharmacol. 2001 May;59(5):1277-86
pubmed: 11306713
J Am Soc Nephrol. 2002 Apr;13(4):866-74
pubmed: 11912245
J Pharm Sci. 2002 Dec;91(12):2614-21
pubmed: 12434406
J Steroid Biochem Mol Biol. 2019 Jul;191:105350
pubmed: 30959153
Anal Chim Acta. 2020 Jan 25;1095:38-47
pubmed: 31864629
Clin Transl Sci. 2020 Jul;13(4):693-699
pubmed: 31981398
J Pharm Sci. 2017 Sep;106(9):2245-2250
pubmed: 28495567
Afr J Tradit Complement Altern Med. 2011;8(5 Suppl):152-63
pubmed: 22754069
Drug Metab Dispos. 2007 Feb;35(2):240-5
pubmed: 17079360
J Pharmacol Exp Ther. 2015 Mar;352(3):519-28
pubmed: 25563903
J Pharm Biomed Anal. 2007 Aug 15;44(4):931-7
pubmed: 17531424
Mol Pharm. 2015 Dec 7;12(12):4301-10
pubmed: 26528626
Food Chem Toxicol. 2018 Oct;120:439-447
pubmed: 30031041
J Basic Clin Pharm. 2014 Jun;5(3):79-83
pubmed: 25278671
J Clin Pharmacol. 1999 Jul;39(7):664-9
pubmed: 10392320
Drug Metab Dispos. 2018 May;46(5):552-560
pubmed: 29467215
Clin Pharmacol Ther. 2021 Jan;109(1):55-64
pubmed: 32460379
Drug Metab Dispos. 2020 Oct;48(10):1104-1112
pubmed: 32601103
J Nat Prod. 2014 Apr 25;77(4):766-72
pubmed: 24593257
Eur J Clin Pharmacol. 2012 Feb;68(2):213-7
pubmed: 21870106
Mol Nutr Food Res. 2008 Jul;52(7):755-63
pubmed: 18214849
Gastroenterology. 2006 May;130(6):1793-806
pubmed: 16697742
Curr Drug Metab. 2007 Oct;8(7):676-84
pubmed: 17979655
Anal Bioanal Chem. 2020 Jul;412(18):4273-4286
pubmed: 32347364
Diabetes Care. 2019 Jun;42(6):1027-1033
pubmed: 30885951
Drug Metab Dispos. 2020 Oct;48(10):1018-1027
pubmed: 32591416
Curr Protoc Toxicol. 2012 Nov;Chapter 23:Unit 23.4
pubmed: 23169269
Eur J Clin Pharmacol. 2005 Sep;61(8):567-72
pubmed: 16133554
Planta Med. 2007 Jul;73(8):731-41
pubmed: 17611934
Metabolism. 2008 May;57(5):712-7
pubmed: 18442638
Nat Prod Rep. 2019 Aug 14;36(8):1196-1221
pubmed: 30681109
Phytomedicine. 2000 Jul;7(4):273-82
pubmed: 10969720
J Pharmacol Exp Ther. 2004 Jan;308(1):2-9
pubmed: 14576340
Mol Pharmacol. 2013 Aug;84(2):182-9
pubmed: 23680637
Biol Pharm Bull. 2019;42(7):1226-1229
pubmed: 31257298
Clin Pharmacol Ther. 2008 Jan;83(1):61-9
pubmed: 17495878
J Nat Prod. 2001 Oct;64(10):1286-93
pubmed: 11678652
Drug Des Devel Ther. 2018 Dec 20;13:129-139
pubmed: 30587933
Kidney Int. 2000 Apr;57(4):1608-16
pubmed: 10760096
J Pharmacol Exp Ther. 2019 Jan;368(1):125-135
pubmed: 30314992